secwatch.observer — SEC 8-K summary
======================================

Issuer:     Strata Critical Medical, Inc. (SRTA)
CIK:        0001779128
Form:       8-K
Filed at:   2023-05-11T23:59:59+00:00
Accession:  0001779128-23-000049
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Blade Q1 revenue up 70% to $45.3M; Flight Profit +145% to $7.2M
---------------------------------------------------------------

- Short Distance revenue rose 148% YoY, driven by Blade Europe acquisition, Canada improvement, and Airport demand.
- MediMobility Organ Transport revenue up 111% YoY and 24% sequentially, from new transplant centers and existing client growth.
- Flight Profit (non-GAAP) increased 145% to $7.2M; company cites leverage and expects YoY Adjusted EBITDA improvement.
- Seventh consecutive quarter with results ahead of expectations; no GAAP net income or EPS disclosed in release.
- Management highlights strong liquidity and asset-light model, preserving capital for opportunistic acquisitions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779128/000177912823000049/0001779128-23-000049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779128/000177912823000049/blde-20230511.htm
  HTML page:      https://secwatch.observer/filing/0001779128-23-000049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer